Date
- 2024 (22)
- 2023 (84)
- 2022 (230)
- 2021 (265)
- 2020 (113)
- 2019 (35)
- 2018 (66)
- 2017 (364)
- 2016 (34)
- 2015 (22)
- 2014 (48)
- 2013 (40)
- 2012 (61)
- 2011 (28)
- 2010 (46)
- 2009 (25)
- 2008 (10)
- 2007 (28)
- 2006 (6)
- 2005 (17)
- 2004 (15)
- 2003 (33)
- 2002 (15)
- 2001 (4)
- 2000 (14)
- 1999 (9)
- 1998 (8)
- 1997 (11)
- 1996 (10)
- 1995 (7)
- 1994 (6)
- 1993 (12)
- 1992 (11)
- 1991 (41)
Results for
"[search-keyword]"
Sponsor content
1740 result(s) found, displaying 751 to 760
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for XERGIC 120 fexofenadine hydrochloride 120 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for XERGIC 180 fexofenadine hydrochloride 180 mg film-coated tablet blister pack.
-
Prescription medicine registrationActive ingredients: icatibant.
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 16/12/2019
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 16/12/2019
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 16/12/2019
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 16/12/2019
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 16/12/2019
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 16/12/2019
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HYDROCORTISONE VIATRIS 4 hydrocortisone 4 mg tablet bottle.